Global Circulating Tumor Cells Market is Poised to Value USD 19.0 Billion By 2032 | CTC Detection & Enrichment Methods to Hold Dominance Says Astute Analytica [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
Innovations in CTC detection and analysis pave the way for liquid biopsies and potential early cancer diagnosis. While CTC rarity and standardization hurdles persist, clinical trial integration highlights the value of CTC technologies in accelerating drug development and improving cancer management strategies. New Delhi, April 03, 2024 (GLOBE NEWSWIRE) -- The global circulating tumor cells market is projected to surpass the market size of US$ 19.0 billion by 2032 from US$ 9.5 billion in 2023 at a CAGR of 8.06% during the forecast period 2024–2032. The staggering cancer incidence paint a concerning picture for the future of global health and directly impact the growth potential of the circulating tumor cells market (CTC). In 2020 alone, 18.1 million new cancer cases were diagnosed worldwide, with an almost even split between men (9.3 million) and women (8.8 million). This staggering burden is alarmingly projected to increase by a further 47% to a staggering 28.4 million cases by 20
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications [Yahoo! Finance]Yahoo! Finance
- QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applicationsGlobeNewswire
- Qiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Qiagen (NYSE: QGEN) had its price target lowered by analysts at Stifel Nicolaus from $55.00 to $45.00. They now have a "hold" rating on the stock.MarketBeat
- Qiagen First Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 4/29/24 - Beat
QGEN
Sec Filings
- 5/1/24 - Form 6-K
- 5/1/24 - Form 6-K
- 3/11/24 - Form 20-F
- QGEN's page on the SEC website